Aganepag (AGN 210937) (Synonyms: AGN 210937) |
رقم الكتالوجGC30572 |
Aganepag (AGN 210937) هو ناهض قوي لمستقبل Prostanoid EP2 ، مع EC50 من 0.19 نانومتر ، ولا يظهر أي نشاط في مستقبل EP4.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 910562-18-4
Sample solution is provided at 25 µL, 10mM.
Aganepag is a potent Prostanoid EP2 receptor agonist, with an EC50 of 0.19 nM, and shows no activity at EP4 receptor. Aganepag can be used in the research of wound healing, scar reduction, scar prevention and wrinkle treatment and prevention.
Aganepag (Compound 3) is a potent Prostanoid EP2 receptor agonist, with an EC50 of 0.19 nM, and shows no activity at EP4. Aganepag can be used in the research of wound healing, scar reduction, scar prevention and wrinkle treatment and prevention[1].
[1]. Robert M. Burk, et al. Compounds and methods for skin repair. WO2014078434A1
Average Rating: 5
(Based on Reviews and 39 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *